Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30152% above fair value
$319.09−3.85 (-1.19%)
Close on Nov 13, 2026Market cap $46.00BP/E –Yield –
Natera EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Natera's EV/EBITDA was 22.3× on Jul 31, 2015.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jul 31, 2015 | 22.3× | – |
See a number that looks wrong?